GLAND - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 20 Dec 25, 03:54 pm

Technical Rating: 3.6

📊 Chart Patterns & Trend: GLAND is trading below both its 50 DMA (1,799 ₹) and 200 DMA (1,803 ₹), showing short-term weakness. Support lies around 1,650–1,670 ₹, while resistance is seen near 1,790–1,800 ₹. The stock is in a bearish reversal phase with oversold signals emerging.

📈 Moving Averages: Current price (1,674 ₹) is below both 50 DMA and 200 DMA, indicating bearish sentiment in the short-to-medium term.

📉 RSI: At 31.9, RSI suggests oversold conditions, signaling potential accumulation zones.

📉 MACD: Strongly negative (-48.4) reflects bearish momentum, suggesting caution until a crossover occurs.

📊 Bollinger Bands: Price is near the lower band, implying limited downside and potential rebound if demand picks up.

📊 Volume Trends: Current volume (70,622) is above the 1-week average (41,075), showing increased participation despite weakness.

🎯 Entry Zone: 1,650–1,670 ₹ (near support and oversold RSI)

🎯 Exit Zone: 1,790–1,800 ₹ (near resistance and upper band)

Positive

• Strong ROCE (15.8%) and ROE (11.6%) highlight efficient capital usage.
• Debt-free balance sheet (Debt-to-equity ratio 0.00) ensures financial stability.
• Dividend yield at 1.06% provides modest income appeal.
• Quarterly PAT growth from 269 Cr. to 302 Cr. shows earnings momentum.
• EPS at 70.2 ₹ reflects solid profitability.

Limitation

• Stock trading below both 50 DMA and 200 DMA shows technical weakness.
• PEG ratio (-6.94) indicates poor alignment between growth and valuation.
• RSI and MACD show strong bearish signals, limiting short-term upside.

Company Negative News

• DII holdings decreased by 0.23%, showing reduced domestic institutional confidence.
• Stock underperforming relative to its 52-week high of 2,131 ₹.

Company Positive News

• FII holdings increased by 0.51%, showing foreign investor confidence.
• Quarterly profit variation at 7.20% highlights steady earnings growth.
• 52-week performance index at 50.9% shows resilience compared to broader market.

Industry

• Industry P/E at 30.6 indicates sector is moderately valued compared to GLAND’s P/E of 23.8.
• Pharmaceutical sector demand expected to remain strong with global healthcare expansion.

Conclusion

⚖️ GLAND is in a bearish reversal phase with oversold RSI and strong negative MACD. Entry near 1,650–1,670 ₹ offers favorable risk-reward, while exits around 1,790–1,800 ₹ are optimal. Watch for MACD crossover and volume recovery to confirm rebound signals. Strong fundamentals and debt-free balance sheet provide stability despite current technical weakness.